Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Algernon Pharmaceuticalsinc (AGN.CN)

Algernon Pharmaceuticalsinc (AGN.CN)
0.0900 x 14000 0.0950 x 11000
Post-market by (Cboe BZX)
0.0900 unch (unch) 03/14/25 [CNSX]
0.0900 x 14000 0.0950 x 11000
Post-market 0.0900 unch (unch) 15:46 ET
Quote Overview for Fri, Mar 14th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.0850
Day High
0.0950
Open 0.0950
Previous Close 0.0900 0.0900
Volume 108,500 108,500
Avg Vol 29,210 29,210
Stochastic %K 73.33% 73.33%
Weighted Alpha -49.89 -49.89
5-Day Change +0.0050 (+5.88%) +0.0050 (+5.88%)
52-Week Range 0.0600 - 0.1650 0.0600 - 0.1650
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 2,457
  • Shares Outstanding, K 27,301
  • Annual Sales, $ 0 K
  • Annual Income, $ -503 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.74
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.37
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $-0.01 on 01/29/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0750 +20.00%
on 03/07/25
Period Open: 0.1000
0.1125 -20.00%
on 02/18/25
-0.0100 (-10.00%)
since 02/14/25
3-Month
0.0650 +38.46%
on 01/03/25
Period Open: 0.0750
0.1225 -26.53%
on 02/10/25
+0.0150 (+20.00%)
since 12/13/24
52-Week
0.0600 +50.00%
on 12/11/24
Period Open: 0.1000
0.1650 -45.45%
on 05/27/24
-0.0100 (-10.00%)
since 03/14/24

Most Recent Stories

More News
Algernon NeuroScience Engages Netcapital Securities for Planned Regulation A Financing

AGN.CN : 0.0900 (unch)
AGNPF : 0.0605 (-8.75%)
Algernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. Sándor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study

AGN.CN : 0.0900 (unch)
AGNPF : 0.0605 (-8.75%)
Algernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare’s USD $170K Equity Investment

AGN.CN : 0.0900 (unch)
AGNPF : 0.0605 (-8.75%)
Algernon Pharmaceuticals Receives Notice of Allowance from USPTO For Repirinast in Kidney Disease Patent

AGN.CN : 0.0900 (unch)
AGNPF : 0.0605 (-8.75%)
Algernon Announces Warrant Extension

AGN.CN : 0.0900 (unch)
AGNPF : 0.0605 (-8.75%)
Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough Study Data at 9th American Cough Conference

VANCOUVER, British Columbia, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0)...

AGN.CN : 0.0900 (unch)
AGNPF : 0.0605 (-8.75%)
The Power Play by The Market Herald Releases New Interviews with First Mining Gold Corp., Algernon Pharmaceuticals, G Mining Ventures, ApartmentLove, and Orvana Minerals

VANCOUVER, BC / ACCESSWIRE / July 18, 2022 / The Power Play by The Market Herald has announced the release of new interviews with First Mining Gold Corp., Algernon Pharmaceuticals, G Mining Ventures, ApartmentLove,...

FF.TO : 0.1400 (+7.69%)
GMIN.VN : 1.700 (unch)
AGN.CN : 0.0900 (unch)
ORV.TO : 0.3750 (+1.35%)
APLV.CN : 0.0250 (unch)
Algernon Pharmaceuticals Provides Update on its Planned Phase 1 Repirinast Chronic Kidney Disease Study

VANCOUVER, British Columbia, July 11, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0)...

AGN.CN : 0.0900 (unch)
AGNPF : 0.0605 (-8.75%)
The Power Play by The Market Herald Releases New Interviews with K9 Gold, Algernon Pharmaceuticals, Deep-South Resources, and Saturn Oil & Gas

VANCOUVER, BC / ACCESSWIRE / July 7, 2022 / The Power Play by The Market Herald has announced the release of new interviews with K9 Gold, Algernon Pharmaceuticals, Deep-South Resources, and Saturn Oil...

KNC.VN : 0.100 (+5.26%)
AGN.CN : 0.0900 (unch)
DSM.VN : 0.045 (-10.00%)
SOIL.VN : 2.270 (+3.18%)
Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study

VANCOUVER, British Columbia, July 07, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0)...

AGN.CN : 0.0900 (unch)
AGNPF : 0.0605 (-8.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis, and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery...

See More

Key Turning Points

3rd Resistance Point 0.1050
2nd Resistance Point 0.1000
1st Resistance Point 0.0950
Last Price 0.0900
1st Support Level 0.0850
2nd Support Level 0.0800
3rd Support Level 0.0750

See More

52-Week High 0.1650
Fibonacci 61.8% 0.1249
Fibonacci 50% 0.1125
Fibonacci 38.2% 0.1001
Last Price 0.0900
52-Week Low 0.0600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals